Amended Statement of Beneficial Ownership (sc 13d/a)
11 July 2020 - 4:04AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Adesto Technologies Corporation
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
00687D
101
(CUSIP Number)
Mark McDonnell
ARCH Venture Corporation
8755 W. Higgins Road Suite 1025
Chicago, IL 60631
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June
29, 2020
(Date of Event which Requires Filing of this
Statement)
If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule
because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
Note: Schedules filed in paper format
shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Persons who respond to the collection of
information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.
CUSIP
No. 00687D
101
|
13D
|
Page
2 of 5 Pages
|
Schedule 13D
|
Item 1.
|
Security and Issuer.
|
This Amendment No. 4 (the “Amendment No. 4”) to the
Schedule 13D filed on November 10, 2015 (the “Original 13D”), as amended by Amendment No. 1 (the “Amendment No.
1”) to the Original 13D filed on July 7, 2017, Amendment No. 2 (the “Amendment No. 2”) to the Original 13D filed
on August 28, 2018, and Amendment No. 3 (the Amendment No. 3”) to the Original 13D filed on January 21, 2020, relating to
the Common Stock, $0.0001 par value per share (the “Common Stock”), of Adesto Technologies Corporation (the “Issuer”)
having its principal executive office at 3600 Peterson Way, Santa Clara, CA 95054, amends the Original 13D as set forth herein.
Certain terms used, but not defined, in this Amendment No. 4 shall
have the meanings assigned thereto in the Original 13D (as amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3). Except
as specifically provided herein, this Amendment No. 4 does not modify any of the information previously reported in the Original
13D, Amendment No. 1, Amendment No. 2 or Amendment No. 3.
|
Item 2.
|
Identity and Background.
|
|
(a)
|
This statement is being filed by: (1) ARCH Venture Fund VI, L.P. (“ARCH Venture Fund VI”), (2) ARCH Venture Partners VI,
L.P. (“AVP VI LP”), which is the sole general partner of ARCH Venture Fund VI, (3) ARCH Venture Partners VI, LLC (“AVP
VI LLC”), which is the sole general partner of AVP VI LP, (4) Clinton Bybee (“Bybee”), (5) Keith Crandell (“Crandell”),
and (6) Robert Nelsen (“Nelsen” and, together with Bybee and Crandell, collectively, the “Managing Directors”
and each individually, a “Managing Director”). Each of the individuals and entities above shall be referred to herein
individually as a “Reporting Person” and collectively as the “Reporting Persons”.
|
|
(b)
|
The business address of each of the Reporting Persons is 8755 West Higgins Road, Suite 1025, Chicago, IL, 60631.
|
|
(c)
|
The principal business of ARCH Venture Fund VI is to invest and assist in developmental and emerging businesses located principally
in the United States. The principal business of AVP VI LP is to act as the general partner of ARCH Venture Fund VI. The principal
business of AVP VI LLC is to act as the general partner of AVP VI LP. The principal business of each of the Managing Directors
is to act as managing directors of AVP VI LLC and a number of affiliated partnerships with similar businesses.
|
|
(d)
|
During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding.
|
|
(e)
|
During the five years prior to the date hereof, none of the Reporting Persons has been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction ending in a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such
laws.
|
|
(f)
|
Each of ARCH Venture Fund VI and AVP VI LP is a Delaware limited partnership. AVP VI LLC is a Delaware limited liability company.
Each of the Managing Directors is a United States citizen.
|
CUSIP
No. 00687D
101
|
13D
|
Page
3 of 5 Pages
|
|
Item 4.
|
Purpose of Transaction.
|
Not Applicable
|
Item 5.
|
Interest in Securities of the Issuer.
|
Each of the Reporting Persons has ceased to beneficially own five
percent (5%) or more of the Issuer’s outstanding Common Stock.
|
Item 7.
|
Material to be Filed as Exhibits.
|
Exhibit 1 – Agreement regarding filing of joint
Schedule 13D.
CUSIP
No. 00687D
101
|
13D
|
Page
4 of 5 Pages
|
Signature
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: July 10, 2020
ARCH Venture
Fund VI, L.P.
By: ARCH Venture Partners VI, L.P.
its General Partner
By: ARCH Venture Partners VI, LLC
its General Partner
By: _____________*____________
Managing Director
ARCH Venture
Partners VI, L.P.
By: ARCH Venture Partners VI, LLC
its General Partner
By: _____________*____________
Managing Director
ARCH VENTURE PARTNERS VI, LLC
By: _____________*____________
Managing Director
*
Clinton Bybee
*
Keith Crandell
*
Robert Nelsen
* By: /s/ Mark McDonnell
Mark McDonnell
as Attorney-in-Fact
* This Amendment No. 4 to Schedule 13D was executed by Mark McDonnell
pursuant to a Power of Attorney filed as Exhibit 24 to the Form 3 relating to the beneficial ownership of shares of Fate Therapeutics,
Inc. (FATE) by the Reporting Persons filed with the Securities Exchange Commission on September 30, 2013 and incorporated herein
in its entirety by reference.
CUSIP
No. 00687D
101
|
13D
|
Page
5 of 5 Pages
|
Exhibit 1
AGREEMENT OF JOINT FILING
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange
Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need
be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Adesto Technologies Corporation.
This Agreement may be executed in any number of counterparts, each
of which shall be deemed an original.
Date: July 10, 2020
ARCH Venture
Fund VI, L.P.
By: ARCH Venture Partners VI, L.P.
its General Partner
By: ARCH Venture Partners VI, LLC
its General Partner
By: _____________*____________
Managing Director
ARCH Venture
Partners VI, L.P.
By: ARCH Venture Partners VI, LLC
its General Partner
By: _____________*____________
Managing Director
ARCH VENTURE PARTNERS VI, LLC
By: _____________*____________
Managing Director
*
Clinton Bybee
*
Keith Crandell
*
Robert Nelsen
* By: /s/ Mark McDonnell
Mark McDonnell
as Attorney-in-Fact
* This Amendment No. 4
to Schedule 13D was executed by Mark McDonnell pursuant to a Power of Attorney filed as Exhibit 24 to the Form 3 relating to the
beneficial ownership of shares of Fate Therapeutics, Inc. (FATE) by the Reporting Persons filed with the Securities Exchange Commission
on September 30, 2013 and incorporated herein in its entirety by reference.
Adesto Technologies (NASDAQ:IOTS)
Historical Stock Chart
From Apr 2024 to May 2024
Adesto Technologies (NASDAQ:IOTS)
Historical Stock Chart
From May 2023 to May 2024